Streetbeat News

Stock Prices

GOOG

GOOGL

MSFT

WFC

Google and Microsoft face backlash for including ads in AI trials without opt-out options, raising concerns among advertisers about marketing budgets and control over ad placements. Wells Fargo temporarily pulled its ad spending from Microsoft.

Portfolio Pulse from Anusuya Lahiri

June 08, 2023 | 12:03 pm

STOK

Over the past 3 months, 8 analysts have published their opinion on Stoke Therapeutics (NASDAQ:STOK) stock, with an average price target of $25.5, implying upside from the current price of $13.08. The current average has increased by 75.86% from the previous average price target of $14.50.

Portfolio Pulse from Benzinga Insights

June 08, 2023 | 12:03 pm

ETSY

Etsy (NASDAQ:ETSY) has received a mix of analyst ratings in the last quarter, with an average price target of $125.56, representing an upside from the current price of $87.57. The current average is a 6.51% decrease from the previous average price target of $134.31.

Portfolio Pulse from Benzinga Insights

June 08, 2023 | 12:02 pm

CVNA

Carvana reports an improved Q2 2023 outlook based on stronger anticipated results from its continued plan to drive profitability, following a record-breaking Q1 2023.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 12:02 pm

AFRM

AMZN

Affirm Holdings (NASDAQ:AFRM) shares gained after Amazon Pay allowed merchants to offer Affirm's pay-over-time options at checkout. Affirm's stock saw 1.75x more calls than puts during Wednesday's session, with traders expecting a 25% surge by June expiration.

Portfolio Pulse from Lisa Levin

June 08, 2023 | 12:01 pm

EADSY

Airbus SE reported a 34% YoY increase in May deliveries, with 63 airplanes delivered to 36 customers. The company has delivered a total of 244 airplanes to 70 customers this year. Airbus also received a firm order for 43 helicopters from Air Corporate in Italy.

Portfolio Pulse from Nabaparna Bhattacharya

June 08, 2023 | 11:59 am

NVS

Novartis' generics unit Sandoz expects to add $3 billion in annual sales over the next five years after spinning out of its parent company. The growth will come from biosimilars and complex generics, with a pipeline of 24 products and over 400 core generic products. Novartis anticipates mid-single-digit net sales growth for Sandoz between 2024 and 2028.

Portfolio Pulse from Vandana Singh

June 08, 2023 | 11:57 am

FDMT

4D Molecular Therapeutics (NASDAQ:FDMT) announced positive interim data from the 4D-710 Phase 1/2 AEROW trial for cystic fibrosis lung disease. The aerosol delivery procedure was well tolerated, and biomarker analyses showed widespread CFTR expression. The company also recently released interim clinical data for wet age-related macular degeneration.

Portfolio Pulse from Vandana Singh

June 08, 2023 | 11:53 am

BW

DG

UEIC

Insiders have recently purchased shares in Dollar General, Babcock & Wilcox Enterprises, and Universal Electronics. Dollar General reported worse-than-expected Q1 results and cut its FY23 sales growth outlook, while Babcock & Wilcox posted a wider-than-expected quarterly loss. Universal Electronics reported better-than-expected quarterly results.

Portfolio Pulse from Lisa Levin

June 08, 2023 | 11:53 am

RPTX

Repare Therapeutics reported initial proof of concept monotherapy data from its Phase 1 MYTHIC trial evaluating lunresertib in advanced solid tumors. Preliminary antitumor activity was observed, and early clinical combination insights demonstrated greater antitumor activity with lunresertib plus camonsertib. The tolerability profile of lunresertib monotherapy appears favorable.

Portfolio Pulse from Vandana Singh

June 08, 2023 | 11:49 am